MODULATION OF MULTIDRUG-RESISTANCE - AT THE THRESHOLD

被引：205
作者：
SIKIC, BI
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1993年 / 11卷 / 09期
关键词：
D O I：
10.1200/JCO.1993.11.9.1629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1629 / 1635
页数：7
相关论文
共 58 条
[41]   VERAPAMIL AND ADRIAMYCIN IN THE TREATMENT OF DRUG-RESISTANT OVARIAN-CANCER PATIENTS [J].
OZOLS, RF ;
CUNNION, RE ;
KLECKER, RW ;
HAMILTON, TC ;
OSTCHEGA, Y ;
PARRILLO, JE ;
YOUNG, RC .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :641-647
[42]   A PHASE-I STUDY ON THE REVERSAL OF MULTIDRUG RESISTANCE (MDR) INVIVO - NIFEDIPINE PLUS ETOPOSIDE [J].
PHILIP, PA ;
JOEL, S ;
MONKMAN, SC ;
DOLEGAOSSOWSKI, E ;
TONKIN, K ;
CARMICHAEL, J ;
IDLE, JR ;
HARRIS, AL .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :267-270
[43]   IMMUNOHISTOCHEMICAL DETECTION OF THE MULTIDRUG TRANSPORT PROTEIN P170 IN HUMAN NORMAL-TISSUES AND MALIGNANT-LYMPHOMAS [J].
PILERI, SA ;
SABATTINI, E ;
FALINI, B ;
TAZZARI, PL ;
GHERLINZONI, F ;
MICHIELI, MG ;
DAMIANI, D ;
ZUCCHINI, L ;
GOBBIS, M ;
TSURUO, T ;
BACCARANI, M .
HISTOPATHOLOGY, 1991, 19 (02) :131-140
[44]   MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA [J].
PIRKER, R ;
WALLNER, J ;
GEISSLER, K ;
LINKESCH, W ;
HAAS, OA ;
BETTELHEIM, P ;
HOPFNER, M ;
SCHERRER, R ;
VALENT, P ;
HAVELEC, L ;
LUDWIG, H ;
LECHNER, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) :708-712
[45]   VERAPAMIL REVERSAL OF CLINICAL DOXORUBICIN RESISTANCE IN HUMAN CANCER - A WILSHIRE-ONCOLOGY-MEDICAL-GROUP PILOT PHASE-I-II STUDY [J].
PRESANT, CA ;
KENNEDY, PS ;
WISEMAN, C ;
GALA, K ;
BOUZAGLOU, A ;
WYRES, M ;
NAESSIG, V .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04) :355-357
[46]   PHASE II STUDY OF COMBINING VINBLASTINE AND CYCLOSPORINE-A TO CIRCUMVENT MULTIDRUG RESISTANCE IN RENAL-CELL CANCER [J].
RODENBURG, CJ ;
NOOTER, K ;
HERWEIJER, H ;
SEYNAEVE, C ;
OOSTEROM, R ;
STOTER, G ;
VERWEIJ, J .
ANNALS OF ONCOLOGY, 1991, 2 (04) :305-306
[47]  
RONINSON IBE, 1991, MOL CELLULAR BIOL MU
[48]  
SALMON SE, 1991, BLOOD, V78, P44
[49]  
SCHEPER RJ, 1993, CANCER RES, V53, P1475
[50]   FEASIBILITY OF USING QUININE, A POTENTIAL MULTIDRUG RESISTANCE REVERSING AGENT, IN COMBINATION WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE-LEUKEMIA [J].
SOLARY, E ;
CAILLOT, D ;
CHAUFFERT, B ;
CASASNOVAS, RO ;
DUMAS, M ;
MAYNADIE, M ;
GUY, H .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1730-1736
123456